Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-20

Clinical Trial Update: Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS) [Phase 3]

View source ↗

Summary

Phase 3 CAPPS trial evaluating combined antioxidant strategies and predictive approaches for preeclampsia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED | Results posted: 2018-11-20